drugset / Trial / NCT01406431

Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy Subjects

NCT01406431

Phase 1 Completed 48 enrolled JW Pharmaceutical
RandomizedCrossoverOpen-label

Summary

The purpose of this study is to compare pharmacokinetics between Pitavastatin and Valsartan co-administration and Livalo fixed combination drug in healthy male subjects.

Timeline

Start
2011-08
Primary completion
2011-08
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pitavastatin Small molecule 4 mg
Comparator Valsartan Small molecule 160 mg